C. Lessard

Comparison of cellular accumulation, tissue distribution, and anti-HIV activity of free and liposomal 2',3'-dideoxycytidine.

M. Bergeron, M. Tremblay, D. Beauchamp, 1994, AIDS research and human retroviruses.

Daptomycin may attenuate experimental tobramycin nephrotoxicity by electrostatic complexation to tobramycin

M. Bergeron, D. Carrier, M. Simard, 1994, Antimicrobial Agents and Chemotherapy.

Renal pharmacokinetic changes of gentamicin during enterococcal pyelonephritis

M. Bergeron, C. Lessard, P. Auclair, 1988, Antimicrobial Agents and Chemotherapy.

Significance of intrarenal concentrations of gentamicin for the outcome of experimental pyelonephritis in rats.

M. Bergeron, A. Bastille, C. Lessard, 1982, The Journal of infectious diseases.

L-651,392, a potent leukotriene inhibitor, controls inflammatory process in Escherichia coli pyelonephritis

M. Bergeron, Y. Bergeron, D. Beauchamp, 1994, Antimicrobial Agents and Chemotherapy.

Concentrations of teicoplanin in serum and atrial appendages of patients undergoing cardiac surgery

S. Trottier, M. Bergeron, D. Desaulniers, 1990, Antimicrobial Agents and Chemotherapy.

Concentrations of fusidic acid, cloxacillin, and cefamandole in sera and atrial appendages of patients undergoing cardiac surgery

M. Bergeron, J. Métras, D. Desaulniers, 1985, Antimicrobial Agents and Chemotherapy.

Norfloxacin penetration into human renal and prostatic tissues

M. Bergeron, M. Thabet, R. Roy, 1985, Antimicrobial Agents and Chemotherapy.

Disturbed intrarenal distribution of gentamicin in experimental pyelonephritis due to Escherichia coli.

S. Trottier, M. Bergeron, D. Beauchamp, 1982, The Journal of infectious diseases.

Antibiotic susceptibility profiles of 941 gram-negative bacteria isolated from septicemic patients throughout Canada. The Canadian Study Group.

M. Bergeron, P. Provencher, S. Chamberland, 1992, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Uptake and binding of liposomal 2',3'-dideoxycytidine by RAW 264.7 cells: a three-step process.

M. Bergeron, M. Tremblay, D. Beauchamp, 1995, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.

Encapsulation of foscarnet in liposomes modifies drug intracellular accumulation, in vitro anti‐HIV-1 activity, tissue distribution, and pharmacokinetics

M. Bergeron, D. Beauchamp, S. Perron, 1995, AIDS.

Intrarenal distribution of trimethoprim and sulfamethoxazole

S. Trottier, M. Bergeron, C. Lessard, 1980, Antimicrobial Agents and Chemotherapy.